fusarium has been researched along with Granuloma, Hodgkin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardner, JM; Heffernan, MP; Nelson, MM | 1 |
| Inagawa, H; Kami, M; Kawagoe, S; Kishi, Y; Machida, U; Matsumura, T; Matsushita, H; Miyakoshi, S; Miyazaki, M; Mori, M; Morinaga, S; Muto, Y; Ueyama, J | 1 |
2 other study(ies) available for fusarium and Granuloma, Hodgkin
| Article | Year |
|---|---|
Chronic cutaneous fusariosis.
Topics: Adult; Amphotericin B; Biopsy, Needle; Chronic Disease; Combined Modality Therapy; Debridement; Dermatomycoses; Follow-Up Studies; Fusarium; Hodgkin Disease; Humans; Immunocompromised Host; Immunohistochemistry; Male; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Systemic fusariosis after a preparative regimen including thiotepa, VP-16 and busulfan used for blood stem cell transplantation in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Etoposide; Fatal Outcome; Fusarium; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mycoses; Thiotepa; Transplantation Conditioning | 2001 |